“… metformin 1000 mg group had … significantly greater decline in glucose and HbA1c levels between treatment weeks 0 and 6 month (p = 0.008 and 0.009, respectively), and the declines … with an increase in body mass index (BMI) level (p interaction with BMI = 0.007 and 0.067, respectively).”